The overall goal of the proposed research is to evaluate the uptake of testing and
longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2
negative patients. This model will inform the selection of the outcomes and potential
mediators and moderators of these outcomes, to inform the debate over utility, risks, and
benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.
- 1. Women and men (at least 18 YO) 2. English speaking AND 3. Negative for BRCA1 and
1. Non English speaking patients